BioLife Solutions, Inc.

BioLife Solutions, Inc. is a pioneering developer and supplier of class-defining bioproduction products and services catering to the cell and gene therapy industry. The company's arsenal comprises its proprietary CryoStor® and HypoThermosol® biopreservation media for shipping and storage, the ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system, high capacity cryogenic storage freezers, Stirling Ultracold mechanical freezers, SciSafe biologic storage services, and Sexton Biotechnologies cell processing tools.

Established in 1987 and headquartered in the United States, BioLife Solutions, Inc. boasts a diversified suite of offerings aimed at supporting the burgeoning cell and gene therapy sector. The company is publicly traded on the NASDAQ under ticker symbol BLFS.

BioLife Solutions, Inc.'s comprehensive product lineup and industry-leading services position it as a key player in the bioproduction tools and services sector. With its commitment to innovation and continual development, the company holds promise for investors seeking exposure to the rapidly evolving field of cell and gene therapy. Its existing position and strategic offerings mark it as a viable candidate for potential venture capital investment and a compelling entity to track within the industry.